These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11041106)

  • 21. [Bisphosphonates in the treatment concept of metastatic breast carcinoma].
    Possinger K; Flath B; Akrivakis K
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M91-4. PubMed ID: 8964444
    [No Abstract]   [Full Text] [Related]  

  • 22. Bisphosphonates: expanded roles in the treatment of patients with cancer.
    Viale PH; Sanchez Yamamoto D
    Clin J Oncol Nurs; 2003; 7(4):393-401. PubMed ID: 12929272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should bisphosphonates be the treatment of choice for metastatic bone disease?
    Coleman RE
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):35-41. PubMed ID: 11544574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E; Kumpulainen E
    Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
    Bloomfield DJ
    J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
    Enright K; Clemons M; Chow E
    Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
    Major PP; Cook R
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S10-8. PubMed ID: 12562046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New bisphosphonates in the treatment of bone metastases.
    Averbuch SD
    Cancer; 1993 Dec; 72(11 Suppl):3443-52. PubMed ID: 8242577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates in breast cancer: antitumor effects.
    Aft R
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bisphosphonates and breast cancer].
    Vehmanen L; Saarto T
    Duodecim; 2010; 126(10):1229-37. PubMed ID: 20597352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials.
    Fulfaro F; Casuccio A; Ticozzi C; Ripamonti C
    Pain; 1998 Dec; 78(3):157-169. PubMed ID: 9870569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biphosphonates in oncology].
    Khosravi Shahi P; Díaz Muñoz de la Espada V
    An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of bisphosphonates in patients with metastatic bone disease.
    Berenson JR; Lipton A
    Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [From laundry product to cancer drug--history of a drug class].
    Possinger K
    Med Klin (Munich); 2000 Oct; 95 Suppl 2():3-7. PubMed ID: 11089381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonates for the relief of pain secondary to bone metastases.
    Wong R; Wiffen PJ
    Cochrane Database Syst Rev; 2002; 2002(2):CD002068. PubMed ID: 12076438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The incidence and management of bone metastasis from breast cancer].
    Saeki T; Ookubo K; Takeuchi H; Fujiuchi N
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1054-7. PubMed ID: 16912520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.